文献速递肝病

亚临床甲状腺功能减退与正常低值甲状腺功能与非酒精性脂肪性肝炎及纤维化相关

Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-08-18

该横断面研究纳入425例经活检证实的非酒精性脂肪性肝病(NAFLD)受试者,按甲状腺功能分为严格正常组、亚临床甲状腺功能减退组和正常低值甲状腺功能组。低甲状腺功能者非酒精性脂肪性肝炎(NASH)和进展性纤维化比例更高,多因素分析显示低甲状腺功能与NASH(OR 1.61)和进展性纤维化(OR 2.23)独立相关。

要点

  • 低甲状腺功能者NASH比例为52.4%,严格正常甲状腺功能者为37.2%(P<.01)。
  • 低甲状腺功能者进展性纤维化为21.0%,严格正常甲状腺功能者为10.6%(P<.01)。
  • 多因素分析中低甲状腺功能与NASH(OR 1.61)和进展性纤维化(OR 2.23)独立相关。

核心结论

  • 亚临床甲状腺功能减退和正常低值甲状腺功能是非酒精性脂肪性肝炎和进展性纤维化的独立预测因素,证实了这些疾病之间的关系。

研究设计与样本

  • 横断面研究,纳入2013年1月至2017年1月参加Boramae NAFLD研究的425例经活检证实的NAFLD受试者(平均年龄53岁,52%为男性)。
  • 282例受试者被分配到严格正常甲状腺功能组(血浆促甲状腺激素0.4至2.5 mIU/L)。
  • 低甲状腺功能者分为亚临床甲状腺功能减退组(血浆促甲状腺激素高于4.5 mIU/L且甲状腺激素水平正常,n=59)或正常低值甲状腺功能组(血浆促甲状腺激素2.5至4.5 mIU/L且甲状腺激素水平正常,n=84)。

主要发现

  • 低甲状腺功能者较严格正常甲状腺功能者NASH比例更高(52.4% vs 37.2%),进展性纤维化比例更高(21.0% vs 10.6%),P<.01。
  • 低甲状腺功能者中亚临床甲状腺功能减退者较正常低值甲状腺功能者NASH比例更高(57.6% vs 48.8%),进展性纤维化比例更高(25.4% vs 17.9%),P<.01。
  • 低甲状腺功能者肝脂肪变更广泛,气球样变性和纤维化程度更重。
  • 多因素分析中,低甲状腺功能与NASH显著相关(OR 1.61;95%CI 1.04-2.50;P=.035),与进展性纤维化显著相关(OR 2.23;95%CI 1.18-4.23;P=.014)。
  • NASH和进展性纤维化风险随血浆促甲状腺激素浓度升高而显著增加(趋势P<.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Variations in level of thyroid-stimulating hormone (TSH) within the reference range of thyroid hormone could have negative health effects. We evaluated the effect of plasma TSH levels within the euthyroid range on the severity of histological damage associated with nonalcoholic fatty liver disease (NAFLD). METHODS: We performed a cross-sectional study of 425 subjects with biopsy-proven NAFLD (mean age, 53 years; 52% male) who participated in the Boramae NAFLD study from January 2013 to January 2017. Each subject underwent an anthropometric assessment and laboratory and clinical evaluations. Of the subjects, 282 were assigned to a strict-normal thyroid function group (plasma level of TSH, 0.4 to 2.5 mIU/L). Patients with low thyroid function were assigned to groups of subclinical hypothyroidism (plasma level of TSH above 4.5 mIU/L with a normal thyroid hormone level; n = 59) or low-normal thyroid function (higher plasma TSH level [2.5 to 4.5 mIU/L] with a normal thyroid hormone level; n = 84). Multivariate logistic regression analysis was used to identify factors independently associated with nonalcoholic steatohepatitis (NASH) and advanced fibrosis. RESULTS: NASH and advanced fibrosis were found in higher percentages of subjects with low thyroid function vs strict-normal thyroid function (52.4% vs 37.2% for NASH and 21.0% vs 10.6% for advanced fibrosis; P < .01). Among subjects with low thyroid function, a higher proportion of patients with subclinical hypothyroidism had NASH and associated advanced fibrosis vs patients with low-normal thyroid function (57.6% vs 48.8% for NASH and 25.4% vs 17.9% for advanced fibrosis; P < .01). Subjects with low thyroid function had more extensive hepatic steatosis with greater severity of balloon degeneration and fibrosis. In multivariate analyses, low thyroid function was significantly associated with NASH (odds ratio, 1.61; 95% CI, 1.04-2.50; P = .035) and advanced fibrosis (odds ratio, 2.23; 95% CI, 1.18-4.23; P = .014). Risks of NASH and advanced fibrosis increased significantly with plasma concentration of TSH (Ptrend <.05 for each). CONCLUSIONS: Subclinical hypothyroidism and low-normal thyroid function are independent predictors of NASH and advanced fibrosis, confirming the relationship between these diseases. ClinicalTrials.gov, Number: NCT02206841.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Kim D, Kim W, Joo SK, et al. Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis. Clin Gastroenterol Hepatol. 2017. PMID: 28823829. doi:10.1016/j.cgh.2017.08.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。